Leading the way in improving patients’ lives
SITraN (Sheffield Institute for Translational Neuroscience) is a world-leading centre for research into Motor Neurone Disease, Alzheimer’s and Parkinson’s Disease.
From basic neuroscience research to novel therapies and clinical trials, SITraN’s aim is to improve the lives of patients with neurodegenerative disorders and their families worldwide.
Six million people globally, and 830,000 in the UK, are affected by neurodegenerative diseases. The purpose-built centre was opened in 2010 by her Majesty the Queen and is focussed on translational research – turning research findings into real benefits for patients. The result is a faster turnaround of new knowledge developed in the lab through to improved health for patients.
SITraN was founded through philanthropy and the support it receives means that it can continue to bring together world-leading minds and use revolutionary equipment and technologies to transform patient care, combining all the key expertise under one roof working together towards a single vision.
The centre is having an impact in a number of ways:
- Industrial scale drug screening and next-generation genome sequencing
- Training the next generation of neuroscientists
- Participating in the world’s largest long-term study on Parkinson’s disease
- One of the few research centres in the world with access to new, fast and very reliable methods to produce motor nerves from patient skin cells
- Pipeline of gene therapies (SMA, SOD1 MND) and promising compounds identified for Parkinson’s and Motor Neurone Disease.
Your donations have a huge impact by supporting world-leading academics, providing them with unrivalled infrastructure support and transforming patient care.
To find out more please visit the SITraN website